IL-13/IL13Rα2 activities mediated by SHN3 in GBM cells were PTP1B-dependent but NF-κB-independent, suggesting that IL-13/PTP1B/SHN3 might be an alternative or complementary pathway to NF-κB when necessary. This evidence concerns the gene IL13RA2 and glioblastoma.